Article | May 14, 2015

Shifting Pharma's Mindset: Viewing Quality As Value Creator, Not Cost

Source: Capsugel® | Lonza Pharma & Biotech
FDA, EMA, GMP, GCP

By Sven Stegemann, PhD, Capsugel

After a decade of cost cutting in product development and manufacturing, many pharmaceutical companies have struggled to meet basic quality standards. In recent years, the U.S. Food and Drug Administration (FDA) has shuttered numerous manufacturing sites and banned a variety of products because of Good Manufacturing Practices (GMP) violations. As a result, many companies have experienced substantial hits to both their corporate reputation and profitability.

What can be done to turn the tide? In many ways, it comes down to a simple shift in mindset: viewing quality in terms of the value it creates, rather than its cost.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to:

Capsugel® | Lonza Pharma & Biotech